Anson Funds Management’s DarioHealth DRIO Stock Holding History

Anson Funds Management’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-263	Closed	-$168K	–	38
2017 Q4	$168K	Buy	+263	New	+$178K	0.11%	54

Other funds holding DRIO

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MIM

Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Anson Funds Management's DRIO Position: Q1 2018 in Review

Anson Funds Management sold out of DarioHealth (DRIO) in Q1 2018, closing a stake of 263 shares — an estimated $168K sold.

Anson Funds Management first reported a position in DRIO in Q4 2017 and held it in 1 quarter. The position peaked at $168K in Q4 2017. 12 funds tracked by Wall St. Rank hold DRIO as of Q1 2018.

Anson Funds Management reported no remaining DarioHealth position as of Q1 2018 after selling out during the quarter.
Anson Funds Management sold 263 DarioHealth shares in Q1 2018, an estimated $168K.
Anson Funds Management first reported a position in DarioHealth in Q4 2017 and held it in 1 quarter.
Anson Funds Management's DarioHealth position peaked at $168K in Q4 2017.
12 funds tracked by Wall St. Rank held DarioHealth as of Q1 2018.

Based on Anson Funds Management's 13F filing for Q1 2018, filed 15 May 2018.